- Home
- EIC vs NKTR Comparison
EIC vs NKTR Comparison
Compare EIC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIC
- NKTR
- Stock Information
- Founded
- EIC N/A
- NKTR 1990
- Country
- EIC United States
- NKTR United States
- Employees
- EIC N/A
- NKTR N/A
- Industry
- EIC Finance/Investors Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- EIC Finance
- NKTR Health Care
- Exchange
- EIC Nasdaq
- NKTR Nasdaq
- Market Cap
- EIC 348.9M
- NKTR 558.0M
- IPO Year
- EIC 2019
- NKTR 1994
- Fundamental
- Price
- EIC $13.12
- NKTR $49.89
- Analyst Decision
- EIC
- NKTR Strong Buy
- Analyst Count
- EIC 0
- NKTR 6
- Target Price
- EIC N/A
- NKTR $81.67
- AVG Volume (30 Days)
- EIC 163.6K
- NKTR 1.1M
- Earning Date
- EIC 11-13-2025
- NKTR 11-06-2025
- Dividend Yield
- EIC 11.87%
- NKTR N/A
- EPS Growth
- EIC N/A
- NKTR N/A
- EPS
- EIC 0.70
- NKTR N/A
- Revenue
- EIC $55,581,156.00
- NKTR $74,934,000.00
- Revenue This Year
- EIC $37.84
- NKTR N/A
- Revenue Next Year
- EIC $23.33
- NKTR N/A
- P/E Ratio
- EIC $18.88
- NKTR N/A
- Revenue Growth
- EIC 56.39
- NKTR N/A
- 52 Week Low
- EIC $12.10
- NKTR $6.48
- 52 Week High
- EIC $16.71
- NKTR $50.53
- Technical
- Relative Strength Index (RSI)
- EIC 41.86
- NKTR 85.11
- Support Level
- EIC $13.05
- NKTR $42.12
- Resistance Level
- EIC $13.45
- NKTR $50.53
- Average True Range (ATR)
- EIC 0.18
- NKTR 3.36
- MACD
- EIC -0.07
- NKTR 1.49
- Stochastic Oscillator
- EIC 8.17
- NKTR 97.18
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.